---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-043754"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:49:49.046393+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ZyVersa raises ~$1.7M via warrant exercise inducement at $2.06/share

## Summary
- Existing warrant holders exercise at reduced price of $2.06/share; gross proceeds ~$1.7M.
- Company issues new Series A-2 warrants for 200% of exercised shares, exercise price $2.06, 5-year term.
- Engaged A.G.P./Alliance Global Partners as financial advisor; cash fee $110,000 plus $10k expenses.
- Net proceeds for working capital and general corporate purposes.
- Company to file resale registration statement for new warrant shares by Dec 20, 2024.

## SEC filing metadata
- accession: 0001493152-24-043754
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315224043754/0001493152-24-043754-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315224043754/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-043754
- JSON: https://secwatch.observer/filing/0001493152-24-043754.json
- Plain text: https://secwatch.observer/filing/0001493152-24-043754.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.